Security key
87184Q107
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS)
CUSIP: 87184Q107
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 27,995,500
- Total 13F shares
- 7,667,574
- Share change
- +7,667,574
- Total reported value
- $119,948,000
- Price per share
- $18.15
- Number of holders
- 11
- Value change
- +$119,948,000
- Number of buys
- 11
Report period
Q2 2016
Institutions
11
Top holders
10
SYRS full security history
Newer quarter: Q3 2016
Syros Pharmaceuticals, Inc. SEC filings
Syros Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87184Q107
Recent filing periods:
Top shareholders of SYRS - Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q2 2016
As of 30 Jun 2016,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,667,574 shares.
The largest 10 holders included
FMR LLC, DEERFIELD MANAGEMENT CO, Redmile Group, LLC, Aisling Capital LLC, BAKER BROS. ADVISORS LP, Foresite Capital Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, Alyeska Investment Group, L.P., Casdin Capital, LLC, and Weiss Multi-Strategy Advisers LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2023 Across Filers
Q1 2023 holders
1
Q2 2016 holders
11
Holder diff
10
| Investor | Q1 2023 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.